XAIR
Beyond Air, Inc.
NASDAQ · Healthcare
| Mar 2025 | Mar 2024 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | 3.7M | 1.2M | 873,000 | 1.4M | 7.7M |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | -1.7M | -1.3M | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Total Op. Expenses | — | — | — | — | — |
| Operating Income | -44.5M | -63.0M | -22.2M | -18.1M | -3.1M |
| EBITDA | — | — | — | — | — |
| Below the Line | |||||
| Interest Expense | — | — | — | — | — |
| Pre-Tax Income | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
| Net Income | -46.6M | -60.2M | -22.9M | -19.9M | -6.6M |
| Per Share | |||||
| EPS (basic) | — | — | — | — | — |
| EPS (diluted) | — | — | — | — | — |
| Shares | |||||
| Basic Shares | — | — | — | — | — |
| Diluted Shares | 68M | 33M | 22M | 16M | 8M |